Setmelanotide
Phase 2 Study to Evaluate Safety and Efficacy of RM-493 in Obese Participants
Rhythm · Phase 2 · Completed · Enrollment 74
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Setmelanotide | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |